Morrison Jodie Pope
Insider CIK 1618247 · KERX Interim CEO, Director · TKAI President and CEO, Director · ALRN Director · AKBA Director · QTTB CEO, Director · VERV Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| QTTB Q32 Bio Inc. | S Sale | 2026-10-06 | 2026-10-14 | 3,221 | $8.32 | $26.8K | 340,038 | SEC↗ |
| QTTB Q32 Bio Inc. | S Sale | 2026-08-25 | 2026-08-27 | 9,845 | $16.56 | $163.0K | 343,259 | SEC↗ |
| QTTB Q32 Bio Inc. | S Sale | 2026-08-25 | 2026-08-27 | 9,845 | $16.56 | $163.0K | 343,259 | SEC↗ |
| QTTB Q32 Bio Inc. | A Award | 2026-07-16 | 2026-07-20 | 132,000 | — | $0 | 353,104 | SEC↗ |
| QTTB Q32 Bio Inc. | S Sale | 2026-02-25 | 2026-02-27 | 9,896 | $4.51 | $44.6K | 89,104 | SEC↗ |
| QTTB Q32 Bio Inc. | A Award | 2026-02-24 | 2026-03-20 | 132,000 | — | $0 | 221,104 | SEC↗ |
| QTTB Q32 Bio Inc. | S Sale | 2025-12-02 | 2025-12-04 | 22,506 | $3.46 | $77.9K | 99,000 | SEC↗ |
| QTTB Q32 Bio Inc. | S Sale | 2025-08-26 | 2025-08-28 | 10,494 | $1.80 | $18.9K | 121,506 | SEC↗ |
| VERV Verve Therapeutics, Inc. | D To issuer deriv | 2025-07-25 | 2025-07-28 | 42,200 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | D To issuer deriv | 2025-07-25 | 2025-07-28 | 267,541 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | A Award deriv | 2025-06-05 | 2025-06-06 | 42,200 | — | $0 | 42,200 | SEC↗ |
| QTTB Q32 Bio Inc. | D To issuer deriv | 2025-02-24 | 2025-02-26 | 394,445 | — | $0 | 0 | SEC↗ |
| QTTB Q32 Bio Inc. | D To issuer deriv | 2025-02-24 | 2025-02-26 | 152,700 | — | $0 | 0 | SEC↗ |
| QTTB Q32 Bio Inc. | A Award deriv | 2025-02-24 | 2025-02-26 | 152,700 | — | $0 | 152,700 | SEC↗ |
| QTTB Q32 Bio Inc. | D To issuer deriv | 2025-02-24 | 2025-02-26 | 152,700 | — | $0 | 0 | SEC↗ |
| QTTB Q32 Bio Inc. | A Award deriv | 2025-02-24 | 2025-02-26 | 152,700 | — | $0 | 152,700 | SEC↗ |
| QTTB Q32 Bio Inc. | D To issuer deriv | 2025-02-24 | 2025-02-26 | 16,901 | — | $0 | 0 | SEC↗ |
| QTTB Q32 Bio Inc. | A Award deriv | 2025-02-24 | 2025-02-26 | 16,901 | — | $0 | 16,901 | SEC↗ |
| QTTB Q32 Bio Inc. | A Award deriv | 2025-02-24 | 2025-02-26 | 394,445 | — | $0 | 394,445 | SEC↗ |
| QTTB Q32 Bio Inc. | A Award | 2025-02-24 | 2025-02-26 | 132,000 | — | $0 | 132,000 | SEC↗ |
| VERV Verve Therapeutics, Inc. | A Award deriv | 2024-06-26 | 2024-06-28 | 267,541 | — | $0 | 267,541 | SEC↗ |
| QTTB Q32 Bio Inc. | A Award deriv | 2024-03-25 | 2024-03-27 | 394,445 | — | $0 | 394,445 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | A Award deriv | 2022-06-15 | 2022-06-17 | 54,500 | — | $0 | 54,500 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | A Award deriv | 2021-06-15 | 2021-06-17 | 96,000 | — | $0 | 96,000 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | A Award deriv | 2020-06-17 | 2020-06-18 | 12,500 | — | $0 | 12,500 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | A Award deriv | 2019-06-19 | 2019-06-21 | 25,000 | — | $0 | 25,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2019-06-06 | 2019-06-10 | 20,100 | — | $0 | 20,100 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2019-06-06 | 2019-06-10 | 13,700 | — | $0 | 58,619 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | D To issuer deriv | 2018-12-12 | 2018-12-13 | 110,000 | — | $0 | 0 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2018-12-12 | 2018-12-13 | 11,229 | — | $0 | 11,229 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2018-12-12 | 2018-12-13 | 11,229 | — | $0 | 11,229 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2018-12-12 | 2018-12-13 | 18,716 | — | $0 | 18,716 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2018-12-12 | 2018-12-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | D To issuer | 2018-12-12 | 2018-12-13 | 120,000 | — | $0 | 0 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2018-12-12 | 2018-12-13 | 44,919 | — | $0 | 44,919 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | A Award deriv | 2018-06-30 | 2018-07-12 | 30,000 | — | $0 | 30,000 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | A Award | 2018-06-30 | 2018-07-12 | 10,000 | — | $0 | 120,000 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | A Award deriv | 2018-06-21 | 2018-06-25 | 10,000 | — | $0 | 10,000 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | A Award | 2018-05-10 | 2018-05-14 | 100,000 | — | $0 | 110,000 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | A Award deriv | 2017-07-25 | 2017-07-27 | 20,000 | — | $0 | 20,000 | SEC↗ |
| NVUS Novus Therapeutics, Inc. | A Award deriv | 2017-06-30 | 2017-07-05 | 18,000 | — | $0 | 18,000 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | A Award deriv | 2017-06-09 | 2017-06-20 | 30,000 | — | $0 | 30,000 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | A Award | 2017-06-09 | 2017-06-20 | 10,000 | — | $0 | 10,000 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | A Award deriv | 2016-06-21 | 2016-06-23 | 50,000 | — | $0 | 50,000 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | M Exercise deriv | 2016-01-08 | 2016-01-08 | 8,015 | — | $0 | 0 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | M Exercise deriv | 2016-01-08 | 2016-01-08 | 20,000 | — | $0 | 37,878 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | M Exercise | 2016-01-08 | 2016-01-08 | 20,000 | $1.37 | $27.4K | 57,566 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | M Exercise | 2016-01-08 | 2016-01-08 | 8,015 | $0.63 | $5.0K | 37,566 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | A Award deriv | 2015-12-15 | 2015-12-17 | 189,000 | — | $0 | 189,000 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | M Exercise deriv | 2015-07-29 | 2015-07-30 | 564 | — | $0 | 312,736 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | M Exercise deriv | 2015-07-29 | 2015-07-30 | 7,000 | — | $0 | 8,015 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | M Exercise deriv | 2015-07-29 | 2015-07-30 | 3,000 | — | $0 | 57,878 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | M Exercise | 2015-07-29 | 2015-07-30 | 564 | $1.58 | $891 | 20,115 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | S Sale | 2015-07-29 | 2015-07-30 | 564 | $13.70 | $7.7K | 19,551 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | M Exercise | 2015-07-29 | 2015-07-30 | 7,000 | $0.63 | $4.4K | 26,551 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | M Exercise | 2015-07-29 | 2015-07-30 | 3,000 | $1.37 | $4.1K | 29,551 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | M Exercise deriv | 2015-07-28 | 2015-07-30 | 12,000 | — | $0 | 313,300 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | S Sale | 2015-07-28 | 2015-07-30 | 12,000 | $13.70 | $164.4K | 19,551 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | M Exercise | 2015-07-28 | 2015-07-30 | 12,000 | $1.58 | $19.0K | 31,551 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | M Exercise deriv | 2015-07-22 | 2015-07-24 | 2,574 | — | $0 | 0 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | M Exercise deriv | 2015-07-22 | 2015-07-24 | 7,426 | — | $0 | 15,015 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | M Exercise | 2015-07-22 | 2015-07-24 | 2,574 | $2.31 | $5.9K | 12,125 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | M Exercise | 2015-07-22 | 2015-07-24 | 7,426 | $0.63 | $4.7K | 19,551 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | M Exercise deriv | 2015-06-29 | 2015-06-30 | 8,000 | — | $0 | 325,300 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | S Sale | 2015-06-29 | 2015-06-30 | 8,000 | $13.70 | $109.6K | 9,551 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | M Exercise | 2015-06-29 | 2015-06-30 | 8,000 | $1.58 | $12.6K | 17,551 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | M Exercise deriv | 2015-06-26 | 2015-06-30 | 8,000 | — | $0 | 333,300 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | S Sale | 2015-06-26 | 2015-06-30 | 8,000 | $13.83 | $110.6K | 9,551 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | M Exercise | 2015-06-26 | 2015-06-30 | 8,000 | $1.58 | $12.6K | 17,551 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | A Award deriv | 2014-10-15 | 2014-10-17 | 134,134 | — | $0 | 134,134 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | A Award deriv | 2014-09-22 | 2014-09-24 | 165,251 | — | $0 | 165,251 | SEC↗ |